138 related articles for article (PubMed ID: 10336685)
21. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
[TBL] [Abstract][Full Text] [Related]
22. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.
Aziz TZ; Peggs D; Agarwal E; Sambrook MA; Crossman AR
Br J Neurosurg; 1992; 6(6):575-82. PubMed ID: 1361741
[TBL] [Abstract][Full Text] [Related]
23. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR
Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139
[TBL] [Abstract][Full Text] [Related]
24. Further investigations into the pathophysiology of MPTP-induced parkinsonism in the primate: an intracerebral microdialysis study of gamma-aminobutyric acid in the lateral segment of the globus pallidus.
Robertson RG; Graham WC; Sambrook MA; Crossman AR
Brain Res; 1991 Nov; 563(1-2):278-80. PubMed ID: 1786541
[TBL] [Abstract][Full Text] [Related]
25. Alterations in pallidal neuronal responses to peripheral sensory and striatal stimulation in symptomatic and recovered parkinsonian cats.
Rothblat DS; Schneider JS
Brain Res; 1995 Dec; 705(1-2):1-14. PubMed ID: 8821727
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
Kaneda K; Tachibana Y; Imanishi M; Kita H; Shigemoto R; Nambu A; Takada M
Eur J Neurosci; 2005 Dec; 22(12):3241-54. PubMed ID: 16367790
[TBL] [Abstract][Full Text] [Related]
27. Effects of transient focal inactivation of the basal ganglia in parkinsonian primates.
Baron MS; Wichmann T; Ma D; DeLong MR
J Neurosci; 2002 Jan; 22(2):592-9. PubMed ID: 11784807
[TBL] [Abstract][Full Text] [Related]
28. A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys.
Rico AJ; Barroso-Chinea P; Conte-Perales L; Roda E; Gómez-Bautista V; Gendive M; Obeso JA; Lanciego JL
Neurobiol Dis; 2010 Sep; 39(3):381-92. PubMed ID: 20452426
[TBL] [Abstract][Full Text] [Related]
29. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
Boraud T; Bezard E; Bioulac B; Gross CE
Brain; 2001 Mar; 124(Pt 3):546-57. PubMed ID: 11222455
[TBL] [Abstract][Full Text] [Related]
30. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
Mounayar S; Boulet S; Tandé D; Jan C; Pessiglione M; Hirsch EC; Féger J; Savasta M; François C; Tremblay L
Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373
[TBL] [Abstract][Full Text] [Related]
31. Subthalamotomy improves MPTP-induced parkinsonism in monkeys.
Guridi J; Herrero MT; Luquin R; Guillen J; Obeso JA
Stereotact Funct Neurosurg; 1994; 62(1-4):98-102. PubMed ID: 7631095
[TBL] [Abstract][Full Text] [Related]
32. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.
Guridi J; Herrero MT; Luquin MR; Guillén J; Ruberg M; Laguna J; Vila M; Javoy-Agid F; Agid Y; Hirsch E; Obeso JA
Brain; 1996 Oct; 119 ( Pt 5)():1717-27. PubMed ID: 8931592
[TBL] [Abstract][Full Text] [Related]
33. Relative sparing of the dopaminergic innervation of the globus pallidus in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
Schneider JS; Dacko S
Brain Res; 1991 Aug; 556(2):292-6. PubMed ID: 1682010
[TBL] [Abstract][Full Text] [Related]
34. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.
Mavridis M; Degryse AD; Lategan AJ; Marien MR; Colpaert FC
Neuroscience; 1991; 41(2-3):507-23. PubMed ID: 1870701
[TBL] [Abstract][Full Text] [Related]
35. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.
Mitchell IJ; Boyce S; Sambrook MA; Crossman AR
Brain; 1992 Jun; 115 ( Pt 3)():809-24. PubMed ID: 1628204
[TBL] [Abstract][Full Text] [Related]
36. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Rioux L; Frohna PA; Joyce JN; Schneider JS
Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
[TBL] [Abstract][Full Text] [Related]
37. Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys.
Blanchet PJ; Boucher R; Bédard PJ
Brain Res; 1994 Jul; 650(1):32-9. PubMed ID: 7953674
[TBL] [Abstract][Full Text] [Related]
38. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.
Crossman AR; Mitchell IJ; Sambrook MA
Neuropharmacology; 1985 Jun; 24(6):587-91. PubMed ID: 3875056
[TBL] [Abstract][Full Text] [Related]
39. Alteration of pallidal cholinergic activity in MPTP-treated monkeys: effect of dihydro-alpha-ergocryptine (DEK).
Curti D; Izzo E; Benzi G
Neurosci Lett; 1994 Feb; 168(1-2):213-6. PubMed ID: 8028778
[TBL] [Abstract][Full Text] [Related]
40. Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
Schultz W; Studer A; Jonsson G; Sundström E; Mefford I
Neurosci Lett; 1985 Aug; 59(2):225-32. PubMed ID: 3877257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
